65,437 trials
Preventive Medicine
Primary: Time From Taking the First Dose of the Study Drug to the Onset of Influenza/ARVI Symptoms. — 428.8; 275.8 days — p=0.001
Smoking
Primary: Smoking Cessation, Continuous 6-month Abstinence — 13; 10 Participants — p=0.46
Rotator Cuff Tear
Primary: Western Ontario Rotator Cuff Index — 82; 80 score on a scale
Thrombocytopenia · Hematologic Diseases
Primary: Number of Participants With Platelet Count Recovery — 20; 22; 6 Participants
Cat Allergy · Cat Hypersensitivity
Primary: Total Nasal Symptom Score (TNSS) Area Under the Curve (AUC) — 2.46; 2.81; 3.66; 3.10 Total Nasal Symptom Score * Hour — p=0.314
Arteriovenous Fistula
Primary: Percentage of Participants With Target Lesion Primary Patency (TLPP) at 6 Months Post Index Procedure — 71.4; 63 Percentage of Participants — p=0.0562
Dry Eye · Contact Lens Complication
Primary: Contact Lens Comfort — 22.03; 9.83 Units on a Scale — p=<0.001
Prostate Carcinoma Metastatic to the Bone · Castration Resistant Prostate Cancer
Primary: Percentage of Participants With at Least (>=) 1 Responding Bone Lesion Assessed by Total Sodium Fluoride (NaF) Standardized Uptake Value [SUVtotal] at Third 18F-NaF…
Hypogonadism, Male · Physical Activity · Testosterone Deficiency
Primary: Change From Baseline in Lean Mass — 2734; 499; 2268 grams
Rotator Cuff Injury
Primary: Ossification Quality Score (Bony Ingrowth Assessed Via CT) — 42; 36; 15; 24 Suture Anchors
Recurrent Childhood Anaplastic Large Cell Lymphoma · Recurrent Malignant Solid Neoplasm · Recurrent Neuroblastoma
Primary: Maximum-tolerated Dose and Recommended Phase 2 Dose of Crizotinib — 280 mg/m²/dose BID
Blood Pressure
Primary: Validate Non-invasive Blood Pressure Measurement Accuracy for the Vital Detect Blood Pressure Monitor. — 4.40; 4.40; 3.26; 3.26 mmHg
Leukemia · Lymphoma
Primary: Treatment-Related Mortality (TRM) — 18 Participants
Lung Diseases, Interstitial
Primary: Annual Rate of Decline in Forced Vital Capacity - Overall Population — -80.82; -187.78 Milliliter per year — p=<.0001
Cerebral Palsy
Primary: Visual Analogue Scale (VAS) — 6.75; 5.29 units on a scale